International Journal of Radiation Oncology*Biology*Physics
Clinical investigation: head and neckIntensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
Introduction
Nasopharyngeal carcinoma (NPC) is common among Asians, especially the Southern Chinese. However, it is rarely seen among the Caucasian population, representing less than 1% of all cancers in the United States (1). The standard treatment for NPC is radiotherapy alone for early (T1N0) disease, and combined radiotherapy and chemotherapy for more advanced lesions, including those with nodal involvement or T2–4 disease 2, 3. The local control rate for American Joint Committee on Cancer (AJCC) 1992 Stage T1 and T2 tumors ranged from 64% to 95%. However, the control rate decreased to 44–68% in AJCC 1992 Stage T3/T4 tumors. Five-year survival was between 36% and 58% 4, 5, 6, 7, 8, 9, 10.
Tumor control for carcinoma of the nasopharynx is highly correlated with the dose delivered to the tumor. In a series of 107 patients with NPC, local control was significantly improved when >67 Gy was delivered to the tumor target (11). In another series of 118 patients, the improvement of tumor control was attributed not only to the prescription of higher doses of radiation, but also to improvements in technical accuracy (12). Because the nasopharynx is surrounded by many critical normal tissues, accuracy in dose delivery is essential in any dose escalation study.
Intensity-modulated radiation therapy (IMRT) has recently gained popularity in the treatment of head-and-neck cancer. With this technique, the intensity of the radiation beams can be modulated so that a high dose can be delivered to the tumor while significantly reducing the dose to the surrounding normal tissues 13, 14, 15, 16. Xia et al. (17) compared IMRT treatment plans with conventional treatment plans for a case of locally advanced NPC. They concluded that IMRT provided improved tumor target coverage with significantly better sparing of sensitive normal tissue structures in the treatment of locally advanced NPC. Two recent papers also substantiated this finding. The authors stated that because of a lack of major benefit with conventional 3-dimensional treatment planning used only during the boost phase of treatment for NPC, they are currently using IMRT to deliver the entire course of radiation 18, 19.
At our medical center, we have been using IMRT for the treatment of NPC since 1995. Local-regional control rate was 100% in our initial clinical experience of 35 patients (20). These patients were treated primarily with forwardly planned IMRT. Over the past 4 years, we have been using inverse planning for all our patients because this technique allows better sparing of the surrounding normal critical structures (17). The majority of the radiation beams were delivered using either computer-controlled auto-sequencing static multileaf collimator (MLC) or the Peacock system using a dynamic multivane intensity-modulating multileaf collimator, called the MIMiC. In this report, we update our results, and describe the evolution of our techniques in the treatment planning and delivery of IMRT for NPC.
Section snippets
Patient and staging evaluation
Between April 1995 and November 2000, 67 patients underwent IMRT for NPC in the Department of Radiation Oncology, University of CaliforniaSan Francisco. For this analysis, the records of these 67 patients, including the first 35 patients that were reported previously, were reviewed and updated (20).
Pretreatment evaluation included a complete history and physical examination, direct flexible fiberoptic endoscopic examination, complete blood counts, liver function tests, chest X-ray, magnetic
Patient characteristics
There were 20 females and 47 males, with a mean age of 49 (range 17–82). Table 1 shows the T- and N-stage distribution of the patient population according to the 1997 AJCC staging classification. The disease was Stage I in 8 (12%), Stage II in 12 (18%), Stage III in 22 (33%), and Stage IV in 25 (37%). There were 55 Chinese, 3 African-American, 2 Hispanic, 6 white, and 1 Saudi Arabian. Thirty-four patients had nonkeratinizing carcinoma (WHO II), and 33 patients had undifferentiated carcinoma
Discussion
Radiotherapy ± chemotherapy is the primary treatment modality for NPC, preferred over surgery due to its anatomic location. The reported local control rate for T1/T2 tumors ranges between 64% and 95% whereas for T3/T4 tumors, the control rate drops to 44–68% according to the 1992 AJCC staging classification 4, 5, 6, 7, 8, 9, 10. Studies have shown that local control rate increased with dose 11, 12. However, due to the anatomic location of the nasopharynx in proximity to many critical normal
Conclusion
Excellent local-regional control for NPC was achieved with intensity-modulated radiotherapy. IMRT provided excellent tumor target coverage and allowed the delivery of a high dose to the target with significant sparing of the salivary glands and other nearby critical normal tissues. Future trials evaluating more effective chemotherapy regimens ± anti-angiogenic agents in decreasing the rate of distant metastasis in NPC are warranted.
References (53)
- et al.
Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynxPreliminary corroboration of the intergroup experience
Int J Radiat Oncol Biol Phys
(2000) - et al.
Irradiation of nasopharyngeal carcinomaCorrelations with treatment factors and stage
Int J Radiat Oncol Biol Phys
(1984) - et al.
Megavoltage irradiation of epithelial tumors of the nasopharynx
Int J Radiat Oncol Biol Phys
(1981) - et al.
Patterns of failure in carcinoma of the nasopharynxI Failure at the primary site
Int J Radiat Oncol Biol Phys
(1985) - et al.
Smart (simultaneous modulated accelerated radiation therapy) boostA new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy
Int J Radiat Oncol Biol Phys
(1999) - et al.
Parotid gland sparing in patients undergoing bilateral head and neck irradiationTechniques and early results
Int J Radiat Oncol Biol Phys
(1996) - et al.
Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer
Int J Radiat Oncol Biol Phys
(1999) - et al.
Comparison of treatment plans involving intensity modulated radiotherapy for nasopharyngeal carcinoma
Int J Radiat Oncol Biol Phys
(2000) - et al.
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma
Int J Radiat Oncol Biol Phys
(2001) - et al.
Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
Int J Radiat Oncol Biol Phys
(2001)
Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinomaThe University of California-San Francisco experience
Int J Radiat Oncol Biol Phys
A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx
Radiother Oncol
Clinical experience with three dimensional treatment planning
Semin Radiat Oncol
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [Editorial]
Int J Radiat Oncol Biol Phys
Brachytherapy for primary and recurrent nasopharyngeal carcinoma20 years’ experience at Long Beach Memorial
Int J Radiat Oncol Biol Phys
The role of brachytherapy in early-stage nasopharyngeal carcinoma
Int J Radiat Oncol Biol Phys
Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinomaImpact on local control
Int J Radiat Oncol Biol Phys
Selection and delineation of lymph node target volumes in head and neck conformal radiotherapyProposal for standardizing terminology procedure based on the surgical experience
Radiother Oncol
A three-dimensional CT-based target definition for elective irradiation of the neck
Int J Radiat Oncol Biol Phys
Treatment portals for elective radiotherapy of the neckAn inventory in the Netherlands
Radiother Oncol
Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors
Radiother Oncol
Three dimensional variability in patient positional using bite block immobilization in 3D-conformal radiation treatment for ENT tumors
Radiother Oncol
The early changes in salivary gland function during and after radiotherapy given for head and neck cancer
Radiother Oncol
Some factors influencing salivary function when treating with radiotherapy
Int J Radiat Oncol Biol Phys
Late effects of radiation therapy in the head and neck region
Int J Radiat Oncol Biol Phys
Diet and nasopharyngeal carcinoma
Prog Clin Biol Res
Cited by (916)
Development and Validation of Single-Optimization Knowledge-Based Volumetric Modulated Arc Therapy Model Plan in Nasopharyngeal Carcinomas
2024, Advances in Radiation OncologySurvival effect of pretreatment FDG-PET–CT on nasopharyngeal cancer
2023, Journal of the Formosan Medical AssociationPost-irradiation endolymphatic hydrops vs. post-irradiation sudden deafness
2022, Radiotherapy and Oncology